Dominion Aesthetic Technologies, Inc. announced that it has received FDA clearance for its body contouring product, eon FR, which is a non-contact medical device that reduces fat. The device delivers laser energy using a patent-pending powered articulated arm. Eon FR is capable of comfortably reducing fat over a larger surface area than its competitors, which is highly desired by both physicians and patients.

"I am very pleased that eon FR has received its FDA clearance demonstrating the safety and efficacy of our non-contact, medical device," said Janet Campbell, founder, chairman, and CEO of Dominion Aesthetic Technologies, Inc. "Clearance was secured thanks to our world-class team of laser engineers, scientists, physicists, and our incredibly talented scientific advisers who contributed to the study of eon FR."
 
Ms. Campbell says, "I wish to recognize three physicians who led the clinical study on eon FR: Dr. Thomas Fiala in Orlando, Dr. Jill Waibel in Miami, and Dr. Suzanne Kilmer in Sacramento. All three are members of Dominion's Scientific Advisory Committee."
 
The eon FR causes the death of fat cells through apoptosis, a process that takes from six to 12 weeks. After the eon FR body contouring treatment, the body naturally eliminates fat cells through its lymphatic system. The eon FR treatment takes about 15 minutes to perform with no downtime.
 
"The clever engineering of eon FR might well make it the 'next big thing' for non-invasive body contouring," commented Dr. Thomas Fiala, owner of Fiala Aesthetics. "The treatment head simultaneously delivers chilled air to keep our patients comfortable, while the diode laser provides reliable deep heating of the fat for effective apoptosis."